Verify Life Science LLC (CA, USA), health and life sciences company under Alphabet, recently announced its partnerships with four major pharmaceutical companies to allow them to move into the clinical trial market.
Browsing: Collaborations and mergers
Global leaders in life sciences and nonclinical drug development, Envigo (Huntingdon, UK) and LabCorp (NC, USA), have signed an innovative agreement in a bid to expand nonclinical drug development capabilities and create an independent research models provider.
Charles River Laboratories have signed an agreement to acquire Citoxlab for $510 million in a deal that aims to expand their global scale and scientific service portfolio.
Bristol-Myers Squibb (NY, USA) have announced that they will be acquiring Celgene (NJ, USA) this year for a cost of $74 billion.
This week’s round-up includes the discovery of a novel method for mass spectometry and thermal desorption, as well as an update from Waters Corp (MA, USA) on their aquisition of DESI technology exclusive rights.
Find out more about the co-development agreement between Xbrane and STADA for a ranibizumab biosimilar, and about a novel biomarker test for establishing lung cancer risk in smokers in this week’s bioanalytical news round-up.
BioAgilytix (NC, USA) have announced their partnership with Sword Bio (IL, USA), to expand their bioanalytical services to include Sword Bio’s detection platform for immunoassays.
Read time: 2 mins
Read more about the latest advances in proteomics this week in our themed weekly news round-up, including news regarding a new clinical market license for a predictive diagnostic test for diabetic kidney disease, and a new device for in vivo real-time proteomics in surgical oncology.
Read time: 1 min
Citoxlab Group (Évreux, France) has announced it will acquire Solvo Biotechnology (Budaörs, Hungary) securing its position as a leader among the top five non-clinical CROs.
Charles River (MA, USA) to expand global position with the procurement of global CRO, MPI Research (MI, USA).